Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

NASA selects GE Healthcare Cardiovascular Ultrasound system

The National Aeronautics and Space Administration (NASA) has selected GE Healthcare’s Vivid q Cardiovascular Ultrasound system to deliver it to the International Space Station (ISS) on its final space shuttle flight.

Vivid q is a lightweight diagnostic ultrasound system about the size of a laptop which is designed for cardiovascular imaging and enables assessment of LV function and cardiac performance.

NASA will use Vivid q on-board ISS as part of its human research program to help assess the impact of long duration microgravity space flight on astronauts.

A European Space Agency experiment – Vascular Echography (Vessel Imaging) will use the device to help evaluate changes in central and peripheral blood vessel wall properties (thickness and compliance) and cross-sectional areas of station astronauts during and after long-term exposure to microgravity.

The Vivid q device will be used for general crew health assessment, and in NASA space research investigations such as Integrated Cardiovascular, which looks at the weakening of heart muscles associated with long-duration spaceflight.

It is also used at the Integrated Resistance and Aerobic Training Study (Sprint) to evaluate the use of Vivid q to minimize loss of muscle, bone, and cardiovascular function in astronauts.

Vivid q may also be used in NASA’s New Millennium Observatory Network (NeMO Net) extreme mission operation, providing underwater space simulation.

NeMO Net is a near-real-time data communications system which links instruments located in a submarine volcano, one mile underwater and 300 miles offshore of Oregon, to the Internet.